Formoterol by Pressurized Metered-Dose Aerosol or Dry Powder on Airway Obstruction and Lung Hyperinflation in Partially Reversible COPD-Reference-Cited by-同舟云学术

Formoterol by Pressurized Metered-Dose Aerosol or Dry Powder on Airway Obstruction and Lung Hyperinflation in Partially Reversible COPD

Published:2011-10 Issue:5 Volume:24 Page:235-243
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Brusasco Vito¹,Canonica G. Walter²,Negro Roberto Dal³,Scano Giorgio⁴,Paggiaro Pierluigi⁵,Fabbri Leonardo M.⁶,Barisione Giovanni⁷,D'Amato Gennaro⁸,Varoli Guido⁹,Baroffio Michele¹,Milanese Manlio¹⁰,Mereu Carlo¹⁰,Crimi Emanuele¹

Affiliation:

1. Unità Operativa di Fisiopatologia Respiratoria, Department of Internal Medicine, University of Genoa, Italy.

2. Clinica di Malattie dell'Apparato Respiratorio e Allergologia, Department of Internal Medicine, University of Genoa, Italy.

3. Unità Operativa di Pneumologia, Hospital of Bussolengo (Verona), Italy.

4. Unità Operativa di Riabilitazione Respiratoria, Fondazione Don Carlo Gnocchi ONLUS, Pozzolatico (Florence), Italy.

5. U.O. Pneumologia e Fisiopatologia Respiratoria, Dipartimento Cardiotoracico, University of Pisa, Italy.

6. Clinica di Malattie dell'Apparato Respiratorio, University of Modena, Italy.

7. Unità Operativa di Medicina Preventiva e del Lavoro, Laboratorio di Fisiopatologia Respiratoria, San Martino Hospital, Genoa, Italy.

8. Divisione di Malattie Respiratorie e Allergiche, Dipartimento di Malattie Respiratorie, High Speciality Hospital “A.Cardarelli,” Naples, Italy.

9. Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy.

10. Struttura Complessa di Pneumologia, S. Corona Hospital, Pietra Ligure (Savona), Italy.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jamp.2010.0862

Reference27 articles.

1. Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease

2. Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

3. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest

4. Inspiratory Capacity, Dynamic Hyperinflation, Breathlessness, and Exercise Performance during the 6-Minute-Walk Test in Chronic Obstructive Pulmonary Disease

5. Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD;Expert Opinion on Drug Delivery;2023-02-26

2. GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond;Expert Review of Clinical Pharmacology;2017-05-02

3. A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD;Respiratory Medicine;2016-11

4. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence;Expert Review of Respiratory Medicine;2014-05-07

5. Lung function;Outcomes in Clinical Trials;2013-12